US 12,440,495
Application 18/383,992 · Granted Oct 14, 2025
Combination therapy for treatment of myeloproliferative neoplasms
Estimated expiration
June 2, 2041
14y 197d remaining
Earliest effective filing
Jun 2, 2021
+ 20 years
Jun 2, 2041
PTA +0d
Jun 2, 2041
TD cap (US 11,833,155)
Feb 11, 2042
Final
Jun 2, 2041
- Earliest effective filing
- Jun 2, 2021
- + 20 years
- Jun 2, 2041
- PTA +0d
- Jun 2, 2041
- TD cap (US 11,833,155)
- Feb 11, 2042
- Final
- Jun 2, 2041
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- October 26, 2023
- Earliest effective filing
- June 2, 2021
- Issue date
- October 14, 2025
- PTA
- 0 days
- Base expiry (before PTA)
- June 2, 2041
June 2, 2021 + 20 years = June 2, 2041
- Continuation of application 17/337,006, filed Jun 2, 2021, issued as US 11,833,155
- PRO63/078,123 — Provisional — not used for base term
- PRO63/034,214 — Provisional — not used for base term
- PRO63/034,214 — Provisional — not used for base term
- PRO63/078,123 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to February 11, 2042 (earliest expiring referenced patent: US 11,833,155)
US 11,833,155· Application 17/337,006Capping patent
Combination therapy for treatment of myeloproliferative neoplasms
- Filing date
- Jun 2, 2021
- Earliest effective filing
- Jun 2, 2021
- Issue date
- Dec 5, 2023
- PTA
- +254 days
- Calculated expiration
- Feb 11, 2042
Jun 2, 2021 + 20y + 254d PTA = Feb 11, 2042
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
You have the date. Your AI can have the file.
Application 18/383,992 · US 12,440,495
PatentReply compiles the prosecution history behind US 12,440,495: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12440495Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.